A. Guillouzo, A. Corlu, C. Aninat, D. Glaise, F. Morel et al., The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics, Chemico-Biological Interactions, vol.168, issue.1, pp.66-73, 2007.
DOI : 10.1016/j.cbi.2006.12.003

K. Kanebratt and T. Andersson, Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies, Drug Metabolism and Disposition, vol.36, issue.7, pp.1444-52, 2008.
DOI : 10.1124/dmd.107.020016

S. Leite, I. Wilk-zasadna, and J. Zaldivar, Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing, Toxicological Sciences, vol.130, issue.1, pp.106-122, 2012.
DOI : 10.1093/toxsci/kfs232

P. Gunness, D. Mueller, V. Shevchenko, E. Heinzle, M. Ingelman-sundberg et al., 3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies, Toxicological Sciences, vol.133, issue.1, pp.67-78, 2013.
DOI : 10.1093/toxsci/kft021

D. Mueller, L. Kramer, E. Hoffmann, S. Klein, and F. Noor, 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies, Toxicology in Vitro, vol.28, issue.1, pp.104-116, 2014.
DOI : 10.1016/j.tiv.2013.06.024

M. Malinen, L. Kanninen, and A. Corlu, Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels, Biomaterials, vol.35, issue.19, pp.5110-5131, 2014.
DOI : 10.1016/j.biomaterials.2014.03.020
URL : https://hal.archives-ouvertes.fr/hal-01134773

N. Murayama, T. Usui, N. Slawny, C. Chesne, and H. Yamazaki, Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays, Drug Metabolism Letters, vol.9, issue.1, pp.3-7, 2015.
DOI : 10.2174/1872312809666150119104806

T. Otsuji, J. Bin, and A. Yoshimura, A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production, Stem Cell Reports, vol.2, issue.5, pp.734-779, 2014.
DOI : 10.1016/j.stemcr.2014.03.012

P. Seglen, Chapter 4 Preparation of Isolated Rat Liver Cells, Methods Cell Biol, vol.13, pp.29-83, 1976.
DOI : 10.1016/S0091-679X(08)61797-5

H. Jenkins, R. Janda, and C. J. , Clinical and experimental observations on the use of gelatin sponge or foam, Surgery, vol.20, pp.124-156, 1946.

S. Miyayama, K. Yamakado, and H. Anai, Guidelines on the use of gelatin sponge particles in embolotherapy, Japanese Journal of Radiology, vol.24, issue.4, pp.242-50, 2014.
DOI : 10.1007/s11604-014-0292-2

R. Lin and H. Chang, Recent advances in three-dimensional multicellular spheroid culture for biomedical research, Biotechnology Journal, vol.296, issue.9-10, pp.1172-84, 2008.
DOI : 10.1002/biot.200700228

B. Mccright, J. Lozier, and T. Gridley, A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency, Development Feb, vol.129, pp.1075-82, 2002.

K. Lorent, S. Yeo, and O. T. , Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy, Development, vol.131, issue.22, pp.5753-66, 2004.
DOI : 10.1242/dev.01411

M. Hasegawa, K. Kawai, and T. Mitsui, The reconstituted ???humanized liver??? in TK-NOG mice is mature and functional, Biochemical and Biophysical Research Communications, vol.405, issue.3
DOI : 10.1016/j.bbrc.2011.01.042

D. Larrey, C. Funck-brentano, and P. Breil, Effects of erythromycin on hepatic drug-metabolizing enzymes in humans, Biochemical Pharmacology, vol.32, issue.6, pp.1063-1071, 1983.
DOI : 10.1016/0006-2952(83)90626-3

T. Andersson, J. Miners, M. Veronese, and D. Birkett, Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism., British Journal of Clinical Pharmacology, vol.5, issue.Suppl., 1994.
DOI : 10.1111/j.1365-2125.1994.tb04310.x

Y. Shirasaka, J. Sager, J. Lutz, C. Davis, and N. Isoherranen, Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions, Drug Metabolism and Disposition, vol.41, issue.7, pp.1414-1438, 2013.
DOI : 10.1124/dmd.113.051722

K. Pernelle, L. Guevel, R. Glaise, and D. , Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye, Toxicology and Applied Pharmacology, vol.254, issue.3, pp.256-66, 2011.
DOI : 10.1016/j.taap.2011.04.018
URL : https://hal.archives-ouvertes.fr/hal-00740177

K. Zeilinger, G. Holland, and I. Sauer, Time Course of Primary Liver Cell Reorganization in Three-Dimensional High-Density Bioreactors for Extracorporeal Liver Support: An Immunohistochemical and Ultrastructural Study, Tissue Engineering, vol.10, issue.7-8, pp.1113-1137, 2004.
DOI : 10.1089/ten.2004.10.1113

E. Schmelzer, K. Mutig, P. Schrade, S. Bachmann, J. Gerlach et al., Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multi-compartment 3D perfusion bioreactors for extra-corporeal liver support, Biotechnology and Bioengineering, vol.19, issue.Suppl 4, pp.817-844, 2009.
DOI : 10.1002/bit.22283

K. Nakamura, R. Mizutani, and A. Sanbe, Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system, Journal of Bioscience and Bioengineering, vol.111, issue.1, pp.78-84, 2011.
DOI : 10.1016/j.jbiosc.2010.08.008

H. Suemizu, M. Hasegawa, and K. Kawai, Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice, Biochemical and Biophysical Research Communications, vol.377, issue.1, pp.248-52, 2008.
DOI : 10.1016/j.bbrc.2008.09.124

M. Dandri, M. Burda, and E. Torok, Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus, Hepatology, vol.33, issue.4, pp.981-989, 2001.
DOI : 10.1053/jhep.2001.23314

D. Mercer, D. Schiller, and J. Elliott, Hepatitis C virus replication in mice with chimeric human livers, Nat Med, 2001.

H. Azuma, N. Paulk, and A. Ranade, Robust expansion of human hepatocytes in Fah???/???/Rag2???/???/Il2rg???/??? mice, Nature Biotechnology, vol.43, issue.8, pp.903-913, 2007.
DOI : 10.1038/nbt1326